https://www.gaucher.org.uk/news/protalix_announces_new_clinical_data_on_taliglucerase_alfa_to_be_presented_at_the_world_lysosomal_disease_network_symposium
Protalix Announces New Clinical Data on Taliglucerase Alfa to be Presented at the WORLD Lysosomal...
taliglucerase alfato beat theprotalixannounces
https://happening.etoro.app/s/nyse/PLX/q1-2026-earnings-report
PLX · Q1 2026 earnings · Protalix · Happening
May 28, 2026 - Protalix BioTherapeutics reported Q1 2026 revenue of $33.8M with net income of $18.3M and diluted EPS of $0.22.
plxearningsprotalixhappening
https://protalix.com/index.php/pipeline
Pipeline | Protalix
Recombinant proteins designed to have potentially improved therapeutic profiles that target unmet medical needs
pipelineprotalix
https://quartr.com/companies/protalix-biotherapeutics-inc_15151
Protalix BioTherapeutics (PLX) Investor Relations, Earnings Summary & Outlook
protalix biotherapeuticsinvestor relationsplxearningssummary